Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders

Neurosci Biobehav Rev. 2023 Jan:144:104955. doi: 10.1016/j.neubiorev.2022.104955. Epub 2022 Nov 14.

Abstract

Quercetin is a naturally occurring bioactive flavonoid abundant in many plants and fruits. Quercetin and its derivatives have shown an array of pharmacological activities in preclinical tests against various illnesses and ailments. Owing to its protective role against oxidative stress and neuroinflammation, quercetin is a possible therapeutic choice for the treatment of neurological disorders. Quercetin and its derivatives can modulate a variety of signal transductions, including neuroreceptor, neuroinflammatory receptor, and redox signaling events. The research on quercetin and its derivatives in neurology-related illnesses mainly focused on the targets, such as redox stress, neuroinflammation, and signaling pathways; however, the function of quercetin and its derivatives on specific molecular targets, such as nuclear receptors and proinflammatory mediators are yet to be explored. Findings showed that various molecular targets of quercetin and its derivatives have therapeutic potential against psychological and neurodegenerative disorders.

Keywords: Anxiety; Depression; Neurodegenerative disorders; Psychological disorders (PLDs); Quercetin; Quercetin derivatives.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants
  • Humans
  • Mental Disorders* / drug therapy
  • Neurodegenerative Diseases* / drug therapy
  • Neuroinflammatory Diseases
  • Quercetin / pharmacology
  • Quercetin / therapeutic use

Substances

  • Quercetin
  • Antioxidants